IP Library Granted Patent US 11,773,357
Granted Patent B2
US 11,773,357 · App. 17/078,742 · Granted Oct 3, 2023

Perfusion plate for microarray 3D bioprinting

Inventor: Moo-Yeal Lee (Pepper Pike, OH)
Assignee: Cleveland State University
C12M21/08C12M23/06C12M23/12C12M23/20C12M23/22C12M23/58C12M25/06C12M29/10C12N5/0671G01N33/5014G01N33/5088
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,773,357
App. No.
17/078,742
Granted
Oct 3, 2023
Kind
B2
Abstract

A perfusion plate that can be combined with pillar plates containing cell layers is disclosed. The perfusion plate can have an inflow reservoir and an outflow reservoir connected by at least one channel, which fluidly connects the perfusion wells to the reservoirs for the flow of a fluid such as growth media. A perfusion plate can be part of an assembly containing a pillar plate, a lid, and a transparent bottom for visualizing cell growth in the perfusion wells. The perfusion-pillar plate assembly can facilitate perfusion-based tissue culture and tissue communication for high throughput, high-content, drug screening.

Claims (37)

1. A method of operating a perfusion plate, comprising the steps of:

encapsulating a cell spheroid in a hydrogel on the top end of at least one pillar on a pillar plate, wherein:

a cell spheroid is created in a well on an ultralow-attachment (ULA) well plate;

a hydrogel is deposited into the top end of the at least one pillar on the pillar plate, wherein:

the top end of the at least one pillar comprises an outer-wall and a base;

the top end of the at least one pillar containing the hydrogel is inserted into the well containing the cell spheroid; and

the pillar plate and well plate are inverted, allowing the cell spheroid to transfer from the well to the top end of the at least one pillar and encapsulate into the hydrogel;

removing the ULA well plate from the pillar plate;

inverting and submerging the top end of the at least one pillar having the cell spheroid encapsulated in the hydrogel into a perfusion well of a perfusion plate, wherein the perfusion plate comprises a first reservoir and a second reservoir, wherein the first reservoir and the second reservoir are fluidly connected;

adding a first volume of media fluid to the first reservoir of the perfusion plate; and

incubating the perfusion plate and pillar plate in an incubator for cell culture.

2. The method of claim 1 , further comprising the steps of:

adding a second volume of media fluid to the second reservoir; and

placing the perfusion plate and pillar plate on a rocker to generate a bidirectional flow of the first volume of media fluid and the second volume of media fluid.

3. The method of claim 1 , further comprising the steps of:

removing a second volume of media fluid from the second reservoir,

placing the perfusion plate and pillar plate on a flat surface to generate a unidirectional flow of the first volume of media fluid.

4. The method of claim 1 , wherein:

the pillar plate comprises at least a first and second row of multiple pillars;

a first type of cell spheroid is encapsulated on the top ends of the pillars in the first row of multiple pillars; and

a second type of cell spheroid is encapsulated on the top ends of the pillars in the second row of multiple pillars.

5. A method of loading cells from a well plate to a pillar plate, comprising the steps of:

loading cells into a plurality of wells in an ultralow-attachment (ULA) well plate;

adding a hydrogel to a plurality of pillar-microwells on a pillar plate;

sandwiching the plurality of pillar-microwells on the pillar plate into the plurality of wells of the ULA well plate;

inverting the ULA well plate and the pillar plate; and

allowing the cells to precipitate and encapsulate into the hydrogel.

6. The method of claim 5 , wherein the ULA well plate is one of a microtiter plate and a perfusion plate.

7. The method of claim 5 , wherein the cells loaded into the plurality of wells of the ULA well plate comprise one or more of: human and animal cells, microbials, fungi, yeasts, and viruses.

8. The method of claim 5 , further comprising the steps of:

removing the ULA well plate from the pillar plate, and

sandwiching the pillar plate with a second well plate having at least one well, wherein

the second well plate is one of a ULA plate, a microtiter plate, and a perfusion plate, and wherein the cells remain incubated.

9. The method of claim 8 , further comprising the steps of:

removing the pillar plate from the second well plate;

rotating the pillar plate 90 degrees; and

sandwiching the pillar plate with the second well plate having at least one well to induce cell-cell communications.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jan 30, 2024
From: CLEVELAND CLINIC FOUNDATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 066286/0487 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 9, 2021
From: LEE, MOO-YEAL
To: CLEVELAND STATE UNIVERSITY
Reel/Frame 055263/0790 →
Continuity (2)
Provisional Application 62926022 · Oct 25, 2019
Related Publication 20210123007A1 · Apr 29, 2021